Literature DB >> 23073954

Strategies to help a smoker who is struggling to quit.

Nancy A Rigotti1.   

Abstract

Tobacco use is the leading preventable cause of death worldwide. Stopping tobacco use benefits virtually every smoker. Most of the 19% of US residents who smoke want to quit and have tried to do so. Most individual quit attempts fail, but two-thirds of smokers use no treatment when trying to quit. Treating tobacco dependence is one of the most cost-effective actions in health care. With a brief intervention, physicians can prompt smokers to attempt to quit and connect them to evidence-based treatment that includes pharmacotherapy and behavioral support (ie, counseling). Physicians can link smokers to effective counseling support offered by a free national network of telephone quit lines. Smokers who use nicotine replacement therapy (NRT), bupropion, or varenicline when trying to quit double their odds of success. The most effective way to use NRT is to combine the long-acting nicotine patch with a shorter-acting product (lozenge, gum, inhaler, or nasal spray) and extend treatment beyond 12 weeks. Observational studies have not confirmed case reports of behavior changes associated with varenicline and bupropion, and these drugs' benefits outweigh potential risks. A chronic disease management model is effective for treating tobacco dependence, which deserves as high a priority in health care systems as treating other chronic diseases like diabetes and hypertension.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23073954      PMCID: PMC4562427          DOI: 10.1001/jama.2012.13043

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  52 in total

1.  Quitting smoking among adults--United States, 2001-2010.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2011-11-11       Impact factor: 17.586

Review 2.  Online support for smoking cessation: a systematic review of the literature.

Authors:  Lion Shahab; Andy McEwen
Journal:  Addiction       Date:  2009-11       Impact factor: 6.526

Review 3.  Risk of serious adverse cardiovascular events associated with varenicline: a systematic review and meta-analysis.

Authors:  Sonal Singh; Yoon K Loke; John G Spangler; Curt D Furberg
Journal:  CMAJ       Date:  2011-07-04       Impact factor: 8.262

4.  Efficacy of varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs placebo or sustained-release bupropion for smoking cessation: a randomized controlled trial.

Authors:  Douglas E Jorenby; J Taylor Hays; Nancy A Rigotti; Salomon Azoulay; Eric J Watsky; Kathryn E Williams; Clare B Billing; Jason Gong; Karen R Reeves
Journal:  JAMA       Date:  2006-07-05       Impact factor: 56.272

Review 5.  Telephone counselling for smoking cessation.

Authors:  L F Stead; R Perera; T Lancaster
Journal:  Cochrane Database Syst Rev       Date:  2006-07-19

Review 6.  Nicotine receptor partial agonists for smoking cessation.

Authors:  Kate Cahill; Lindsay F Stead; Tim Lancaster
Journal:  Cochrane Database Syst Rev       Date:  2011-02-16

7.  A randomized, double-blind, placebo-controlled study evaluating the safety and efficacy of varenicline for smoking cessation in patients with schizophrenia or schizoaffective disorder.

Authors:  Jill M Williams; Robert M Anthenelli; Chad D Morris; Joan Treadow; John R Thompson; Carla Yunis; Tony P George
Journal:  J Clin Psychiatry       Date:  2012-05       Impact factor: 4.384

Review 8.  Nicotine replacement therapy for smoking cessation.

Authors:  L F Stead; R Perera; C Bullen; D Mant; T Lancaster
Journal:  Cochrane Database Syst Rev       Date:  2008-01-23

Review 9.  Clonidine for smoking cessation.

Authors:  S G Gourlay; L F Stead; N L Benowitz
Journal:  Cochrane Database Syst Rev       Date:  2004

10.  Varenicline and suicidal behaviour: a cohort study based on data from the General Practice Research Database.

Authors:  D Gunnell; D Irvine; L Wise; C Davies; R M Martin
Journal:  BMJ       Date:  2009-10-01
View more
  19 in total

1.  Smoking Cessation in a Chronic Pancreatitis Population.

Authors:  Samuel Han; Joan Kheder; Lisa Bocelli; Julien Fahed; Amy Wachholtz; Gregory Seward; Wahid Wassef
Journal:  Pancreas       Date:  2016-10       Impact factor: 3.327

2.  Associations Between Comorbid Health Conditions and Quit Outcomes Among Smokers Enrolled in a State Quitline, Arizona, 2011-2016.

Authors:  Uma S Nair; Melanie L Bell; Nicole P Yuan; Betsy C Wertheim; Cynthia A Thomson
Journal:  Public Health Rep       Date:  2018 Mar/Apr       Impact factor: 2.792

3.  Design and initial enrollment in the Vascular Physicians Offer and Report (VAPOR) trial.

Authors:  Emily L Spangler; Benjamin S Brooke; Adam W Beck; Andrew Hoel; Alik Farber; Philip P Goodney
Journal:  J Vasc Surg       Date:  2016-04       Impact factor: 4.268

4.  Referring Hospitalized Smokers to Outpatient Quit Services: A Randomized Trial.

Authors:  Jeffrey L Fellows; Richard A Mularski; Michael C Leo; Charles J Bentz; Lisa A Waiwaiole; Melanie C Francisco; Kimberly Funkhouser; Catherine M Stoney
Journal:  Am J Prev Med       Date:  2016-10       Impact factor: 5.043

5.  Electronic Cigarettes and Communication: An Examination of College Students' Perceptions of Safety and Use.

Authors:  E Paige Hart; Clara G Sears; Joy L Hart; Kandi L Walker
Journal:  Ky J Commun       Date:  2017

Review 6.  The pharmacological approach to the elderly COPD patient.

Authors:  Timothy E Albertson; Michael Schivo; Amir A Zeki; Samuel Louie; Mark E Sutter; Mark Avdalovic; Andrew L Chan
Journal:  Drugs Aging       Date:  2013-07       Impact factor: 3.923

7.  Smoking Cessation for Smokers Not Ready to Quit: Meta-analysis and Cost-effectiveness Analysis.

Authors:  Ayesha Ali; Cameron M Kaplan; Karen J Derefinko; Robert C Klesges
Journal:  Am J Prev Med       Date:  2018-06-12       Impact factor: 5.043

Review 8.  Tobacco use treatment in primary care patients with psychiatric illness.

Authors:  Joseph M Cerimele; Abigail C Halperin; Andrew J Saxon
Journal:  J Am Board Fam Med       Date:  2014 May-Jun       Impact factor: 2.657

9.  Should clinicians encourage smoking cessation for every patient who smokes?

Authors:  Michael C Fiore; Timothy B Baker
Journal:  JAMA       Date:  2013-03-13       Impact factor: 56.272

10.  The effect of switching pharmacological intervention during extinction on nicotine-evoked conditioned responding in rats.

Authors:  Steven T Pittenger; Lindsey C Zeplin; Linda P Dwoskin; Rick A Bevins
Journal:  Psychopharmacology (Berl)       Date:  2015-09-14       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.